INS and type 2 diabetes mellitus: Even in the simplest approach, in the case of basal insulin therapy, which is the most popular scheme to initiate insulin treatment for type 2 diabetes, the high level of clinical inertia results in late insulin treatment initiation and suboptimal dosing, both aspects being clearly associated with suboptimal general glycemic control in many type 2 diabetes patients.8, 9